UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities

Angewandte Chemie International Edition, 2019-12, Vol.58 (49), p.17704-17708

International ed. in English, 2019

Volltextzugriff (PDF)

Lewis Acidic Boranes, Lewis Bases, and Equilibrium Constants: A Reliable Scaffold for a Quantitative Lewis Acidity/Basicity Scale

Chemistry : a European journal, 2021-02, Vol.27 (12), p.4070-4080

2021

Volltextzugriff (PDF)

Lewis Acidity Scale of Diaryliodonium Ions toward Oxygen, Nitrogen, and Halogen Lewis Bases

Journal of the American Chemical Society, 2020-03, Vol.142 (11), p.5221-5233

2020

Volltextzugriff (PDF)

Metal-Pyridoxal Cooperativity in Nonenzymatic Transamination

Journal of the American Chemical Society, 2023-06, Vol.145 (24), p.13357-13370

2023

Volltextzugriff (PDF)

NDIPhos as a platform for chiral supramolecular ligands in rhodium-catalyzed enantioselective hydrogenation

Chemical communications (Cambridge, England), 2023-05, Vol.59 (41), p.6231-6234

2023

Volltextzugriff (PDF)

Hydroarylation of enamides enabled by HFIP via a hexafluoroisopropyl ether as iminium reservoir

Chemical science (Cambridge), 2022-07, Vol.13 (28), p.8436-8443

2022

Volltextzugriff (PDF)

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of clinical oncology, 2012-12, Vol.30 (35), p.4344-4351

2012

Volltextzugriff (PDF)

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2165-2172

2017

Volltextzugriff (PDF)

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3617-3622

2010

Volltextzugriff (PDF)

Synthesis, Structure, and Properties of Amino‐Substituted Benzhydrylium Ions – A Link between Ordinary Carbocations and Neutral Electrophiles

European journal of organic chemistry, 2019-01, Vol.2019 (2-3), p.412-421

2019

Volltextzugriff (PDF)

Biomimetic Approach Toward Enterocin and Deoxyenterocin

Journal of organic chemistry, 2019-02, Vol.84 (3), p.1162-1175

2019

Volltextzugriff (PDF)

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2736-2742

2016

Volltextzugriff (PDF)

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

Journal of clinical oncology, 2004-04, Vol.22 (7), p.1201-1208

2004

Volltextzugriff (PDF)

Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3456-3461

2007

Volltextzugriff (PDF)

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1814-1821

2009

Volltextzugriff (PDF)

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

JNCI : Journal of the National Cancer Institute, 2022-03, Vol.114 (3), p.427-435

2022

Volltextzugriff (PDF)

Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3153-3162

2011

Volltextzugriff (PDF)

Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3535-3541

2006

Volltextzugriff (PDF)

Flashback Foreword: Oxaliplatin Plus LV5FU2 in Colorectal Cancer

Journal of clinical oncology, 2023-11, Vol.41 (33), p.5077-5078

Mayer, Robert J

2023

Volltextzugriff (PDF)

Progress against GI cancer during the American Society of Clinical Oncology's first 50 years

Journal of clinical oncology, 2014-05, Vol.32 (15), p.1521-1530

2014

Volltextzugriff (PDF)

A compendium of potential biomarkers of pancreatic cancer

PLoS medicine, 2009-04, Vol.6 (4), p.e1000046-e1000046

2009

Volltextzugriff (PDF)

Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8706-8712

2005

Volltextzugriff (PDF)

Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3325-3327

MAYER, Robert J

2012

Volltextzugriff (PDF)

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4914-4921

2006

Volltextzugriff (PDF)

Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4109-4115

2008

Volltextzugriff (PDF)

1 – 25 von 2.019

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.831)
Mit Volltextzugriff
(1.647)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities

Lewis Acidic Boranes, Lewis Bases, and Equilibrium Constants: A Reliable Scaffold for a Quantitative Lewis Acidity/Basicity Scale

Lewis Acidity Scale of Diaryliodonium Ions toward Oxygen, Nitrogen, and Halogen Lewis Bases

Metal-Pyridoxal Cooperativity in Nonenzymatic Transamination

NDIPhos as a platform for chiral supramolecular ligands in rhodium-catalyzed enantioselective hydrogenation

Hydroarylation of enamides enabled by HFIP via a hexafluoroisopropyl ether as iminium reservoir

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Synthesis, Structure, and Properties of Amino‐Substituted Benzhydrylium Ions – A Link between Ordinary Carbocations and Neutral Electrophiles

Biomimetic Approach Toward Enterocin and Deoxyenterocin

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803

Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

Flashback Foreword: Oxaliplatin Plus LV5FU2 in Colorectal Cancer

Progress against GI cancer during the American Society of Clinical Oncology's first 50 years

A compendium of potential biomarkers of pancreatic cancer

Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines

Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803

Suchergebnisse filtern